Patents by Inventor M. Rami Reddy

M. Rami Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaromatic inhibitors of fructose 1,6-bisphosphatase
    Patent number: 7312219
    Abstract: Novel FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: December 25, 2007
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy, Mark D. Erion, M. Rami Reddy, Atul Agurwal
  • Purine inhibitors of fructose-1,6-bisphosphatase
    Patent number: 7285543
    Abstract: Novel purine compounds of Formula 1, pharmaceutically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: October 23, 2007
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Purine inhibitors of fructose-1,6-bisphosphatase
    Patent number: 6967193
    Abstract: Novel purine compounds of the Formula 1, pharmacuetically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: November 22, 2005
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
    Patent number: 6489476
    Abstract: FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: December 3, 2002
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy, Mark D. Erion, M. Rami Reddy, Atul Agarwal
  • Benzimidazole inhibitors of fructose 1,6-bisphosphatase
    Patent number: 6399782
    Abstract: Novel benzimidazole compounds of the following structure and their use as fructose-1,6-bisphosphatase inhibitors is described
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: June 4, 2002
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Srinivas Rao Kasibhatla, K. Raja Reddy, Mark D. Erion, Qun Dang, Gerard R. Scarlato, M. Rami Reddy
  • Indole and azaindole inhibitors of Fructose-1,6-biphosphatase
    Patent number: 6294672
    Abstract: The present invention is directed towards novel azaindole compounds which bind to the AMP site and are potent FBPase inhibitors. The present invention also is directed towards the clinical use of the novel FBPase inhibitors as a method of treatment or prevention of diseases responsive to lowered blood glucose levels.
    Type: Grant
    Filed: January 5, 2000
    Date of Patent: September 25, 2001
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: K. Raja Reddy, Gerard R. Scarlato, Qun Dang, Mark D. Erion, Srinivas Rao Kasibhatla, M. Rami Reddy
  • Purine inhibitors of fructose 1,6-bisphosphatase
    Patent number: 6284748
    Abstract: Novel purine compounds of the following structure and their use as fructose-1,6-bisphosphatase inhibitors is described.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: September 4, 2001
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Benzimidazole inhibitors of fructose 1,6-bisphosphatase
    Patent number: 6110903
    Abstract: Novel benzimidazole compounds of the following structure and their use as fructose-1,6-bisphosphatase inhibitors is described ##STR1##
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: August 29, 2000
    Assignee: Sankyo Company Ltd.
    Inventors: Srinivas Rao Kasibhatla, K. Raja Reddy, Mark D. Erion, Qun Dang, Gerard R. Scarlato, M. Rami Reddy
  • Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
    Patent number: 6054587
    Abstract: Novel indole and azaindole compounds of the following structure and their use as fructose-1,6-bisphosphatase inhibitors is described: ##STR1## and pharmaceutically acceptable prodrugs and salts thereof.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: April 25, 2000
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: K. Raja Reddy, Gerard R. Scarlato, Qun Dang, Mark D. Erion, Srinivas Rao Kasibhatla, M. Rami Reddy